Sign Out
Use in pregnancy: There are no adequate or well controlled studies of Granisetron in human pregnancy. Teratogenic effects were not observed in animal studies. Because of the low safety margin indicated by the animal studies and because animal reproduction studies are not always predictive of human response, Kytron Solution for Injection/Infusion 3 mg/3 ml should be used during pregnancy only if clearly needed.
Use in Lactation: There are no data on the excretion of Granisetron in human breast milk, therefore use of the drug during lactation should be limited to situations where the potential benefit to the mother justifies the potential risk to the nursing infant.
